Deferoxamine (Standard)

Cat. No.: HY-B1625R Purity: ≥98%: Handling Instructions Technical Support

Deferoxamine (Standard) is the analytical standard of Deferoxamine. This product is intended for research and analytical applications. Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19.

For research use only. We do not sell to patients.

Deferoxamine (Standard) Chemical Structure

CAS No. : 70-51-9

Size	Stock	Quantity
1 mg	Get quote 5 - 7 weeks 4 - 6 weeks 4 - 6 weeks	Estimated Time of Arrival: December 31
5 mg	Get quote 5 - 7 weeks 4 - 6 weeks 4 - 6 weeks	Estimated Time of Arrival: December 31
10 mg	Get quote 5 - 7 weeks 4 - 6 weeks 4 - 6 weeks	Estimated Time of Arrival: December 31
25 mg	Get quote 5 - 7 weeks 4 - 6 weeks 4 - 6 weeks	Estimated Time of Arrival: December 31
50 mg	Get quote 5 - 7 weeks 4 - 6 weeks 4 - 6 weeks	Estimated Time of Arrival: December 31
100 mg	Get quote 5 - 7 weeks 4 - 6 weeks 4 - 6 weeks	Estimated Time of Arrival: December 31
200 mg	Get quote
500 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Product Information
Purity & Documentation
Customer Review

Description	Deferoxamine (Standard) is the analytical standard of Deferoxamine . This product is intended for research and analytical applications. Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19.
Molecular Weight	560.68
Formula	C₂₅H₄₈N₆O₈
CAS No.	70-51-9
SMILES	O=C(N(CCCCCN)O)CCC(NCCCCCN(C(CCC(NCCCCCN(C(C)=O)O)=O)=O)O)=O
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Handling Instructions (2659 KB)